These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18360056)

  • 1. Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension.
    Nakamoto M; Ohya Y; Shinzato T; Mano R; Yamazato M; Sakima A; Takishita S
    Hypertens Res; 2008 Feb; 31(2):353-61. PubMed ID: 18360056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats.
    Shinzato T; Ohya Y; Nakamoto M; Ishida A; Takishita S
    Hypertens Res; 2007 Sep; 30(9):863-73. PubMed ID: 18037780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
    Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
    J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pioglitazone on high-fat-diet-induced ventricular remodeling and dysfunction in rats.
    Tian YQ; Li SS; Su XD; Zhang GZ; Zhao JJ; Li GW; Wang L
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):223-8. PubMed ID: 22031275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):324-33. PubMed ID: 22261714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
    J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
    Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
    Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of salt-sensitive hypertension in Dahl rats reveals a link between cardiac fibrosis and high cholesterol.
    Wendt N; Schulz A; Qadri F; Bolbrinker J; Kossmehl P; Winkler K; Stoll M; Vetter R; Kreutz R
    Cardiovasc Res; 2009 Feb; 81(3):618-26. PubMed ID: 18824493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
    Tinel H
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):75-82. PubMed ID: 17666919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats.
    Kobayashi N; Nishikimi T; Horinaka S; Ishimitsu T; Matsuoka H
    Atherosclerosis; 2001 Jun; 156(2):255-65. PubMed ID: 11395021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet.
    Namikoshi T; Tomita N; Satoh M; Haruna Y; Kobayashi S; Komai N; Sasaki T; Kashihara N
    Hypertens Res; 2008 Apr; 31(4):745-55. PubMed ID: 18633187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone on cardiac and adipose tissue pathology in rats with metabolic syndrome.
    Matsuura N; Asano C; Nagasawa K; Ito S; Sano Y; Minagawa Y; Yamada Y; Hattori T; Watanabe S; Murohara T; Nagata K
    Int J Cardiol; 2015 Jan; 179():360-9. PubMed ID: 25464487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High salt intake accelerated cardiac remodeling in spontaneously hypertensive rats: time window of left ventricular functional transition and its relation to salt-loading doses.
    Gao F; Han ZQ; Zhou X; Shi R; Dong Y; Jiang TM; Li YM
    Clin Exp Hypertens; 2011; 33(7):492-9. PubMed ID: 21529316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
    Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Yoshida J; Miwa T; Sugawara M; Yamaguchi Y; Ookawara T; Suzuki K; Hori M
    Cardiovasc Res; 2002 Jul; 55(1):76-82. PubMed ID: 12062710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
    Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
    Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.
    Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Feb; 51(2):296-301. PubMed ID: 18158350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.